| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.32 | 2e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |